- UroToday Home
- Recent Abstracts
- Pelvic Health & Reconstruction
Overactive Bladder
Leptin - a novel pharmacological agent for treatment of women with overactive bladder symptoms? - Abstract
October 9, 2012
Efficacy and adverse events of antimuscarinics for treating overactive bladder: Network meta-analyses - Abstract
October 5, 2012
Cost-effectiveness analysis of antimuscarinic agents for the treatment of overactive bladder - Abstract
October 2, 2012
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection - Abstract
October 1, 2012
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis - Abstract
September 28, 2012
Detrusor myectomy: Long-term functional outcomes - Abstract
September 27, 2012
Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: A pilot study - Abstract
September 26, 2012
Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools - Abstract
September 25, 2012
Oxybutynin: Past, present, and future - Abstract
September 24, 2012
Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms - Abstract
September 20, 2012
Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: An update - Abstract
September 19, 2012
Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women - Abstract
September 18, 2012
Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder - Abstract
September 17, 2012